Find your path to Melissa
267 people in our graph share verified history with Melissa — schools, employers, funds. One of them is your warm intro.
Francisco GimenezunlockedMelissa: together at University of California, San Francisco (2008–2010)
×2Melissa: together at University of California, San Francisco
×2Melissa: together at The Francis Crick Institute
×3Melissa: together at Cancerresearchuk
About
Melissa Lezameta is a Senior Associate at Epidarex Capital, working in innovation, licensing, and partnering with a focus on oncology and neuroscience. She holds a Ph.D. in Neurobiology and has a background in cancer stem cells, immuno-oncology, CNS, and neural stem cells.
Contact· self-published, not guessed
Experience
- Epidarex CapitalSenior Associatecurrent2026 — present
- Epidarex CapitalAssociate2022 — 2026
- MacomicsBoard Observercurrent2022 — present
- Kynos TherapeuticsBoard Observer2022 — 2024
- EDINBURGH MOLECULAR IMAGING LIMITEDBoard Observer2022 — 2024Edinburgh, Scotland, United Kingdom
- The Francis Crick InstituteSenior Business Manager2021Greater London, England, United Kingdom
- Cancer Research UK (CRUK)Translation executive2019 — 2021Crick Institute, London
- ML Bio ConsultingOwner2018 — 2019Cambridge, UK
- nanomolar.comDirector Of Business Development2018 — 2019Greater Cambridge Area
- University of California, San FranciscoLicensing officer associate at UCSF ITA2014 — 2015San Francisco Bay Area
- Campbell AllianceAssociate Consultant2013 — 2014San Francisco Bay Area
- GeronPost doctoral researcher2011 — 2013
- UCSFPhD/research collaborator2007 — 2010
Skills & more
Stem Cells10In Vitro7Biotechnology11Microscopy10Cell11Oncology2Immunostaining2Cell Culture5Biomarkers1Immunohistochemistry3Cancer3Western Blotting3
+8 more
TransfectionChemistryAssay DevelopmentImmunofluorescenceConfocal MicroscopyCell BiologyMolecular BiologyDrug DevelopmentFrom Melissa's professional profile.
Colleagues at Epidarex Capital
A. Sinclair Dunlop
Managing Partner at Epidarex Capital
Elizabeth Roper
General Partner at Epidarex Capital
Kyparissia Sirinakis
Managing Partner at Epidarex Capital
Lori Gough
Partner at Epidarex Capital
Mary Canning
Partner at Epidarex Capital
Matthew Miessau
Principal at Epidarex Capital
Matthias Steinert
Investment Manager at SIB Innovations- und Beteiligungsgesellschaft
Peter Finan
General Partner at Epidarex Capital
Frequently asked questions
- Who is Melissa Lezameta?
- Melissa Lezameta is a Senior Associate at Epidarex Capital, working in innovation, licensing, and partnering with a focus on oncology and neuroscience. She holds a Ph.D. in Neurobiology and has a background in cancer stem cells, immuno-oncology, CNS, and neural stem cells.
- Where does Melissa Lezameta work?
- Melissa Lezameta is Associate at Epidarex Capital.
- Where did Melissa Lezameta go to school?
- Melissa Lezameta studied at University of California, San Francisco (certificate); Universitat de Valencia/UCSF (Ph.D., Neuroscience); Universidad Complutense de Madrid (Bs + Ms, Biology).
Same school
Also attended University of California, San Francisco144
Douglas CrawfordManaging General Partner at Mission BiocapitalLuke EvninAdvisor at MPM BioImpactCharles White, Ph.D.Principal at Illumina VenturesMatt MaurerInvestor at WVV CapitalAlec NielsenFounder & CEO, Asimov & Venture Partner at Pillar VCStephan ChristgauFounding Partner at EIR Ventures
+ 138 more
Also attended Universidad Complutense de Madrid126
Kike MirallesInvestment Director at Intel CapitalRaúl GallegoGeneral Partner at Inveready Technology Investment GroupPablo GoceAnalyst at Inveready Technology Investment GroupMaria PovedaDirector at Inveready Technology Investment GroupSamantha WulfsonPrincipal at FinTech CollectiveJosé Mª AmusáteguiCo-founder & Partner at Kibo Ventures
+ 120 more
Shared employers
Also worked at Epidarex Capital6
Also worked at Cancer Research UK (CRUK)33
Drew BurdonInvestor at LSP (Life Sciences Partners)Giovanni MariggiInvestor at MedicxiDominic SchmidtGeneral Partner at Advent Life SciencesJoanna SorokaInvestment Partner at Hitachi VenturesMilenko CicmilVenture Partner at Cure VenturesMartin TaylorPrincipal at F-Prime Capital Partners
+ 27 more
Also worked at University of California, San Francisco156
Logan HilleLife Sciences Analyst at CincyTechPaul JennyBoard Chair at CincyTechFrancisco GimenezInvestment Team at 8VCUlrik B. NielsenGeneral Partner at Mission BiocapitalHani GoodarziFounder, Tahoe Therapeutics at Amplify PartnersCharles White, Ph.D.Principal at Illumina Ventures
+ 150 more
